Founded in 1998, MicroPort® (00853.HK) is a global medical technology company committed to breaking barriers in healthcare. Our mission is to provide trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all lives.
Headquartered in Shanghai, China, with regional headquarters in Greater China and North America, MicroPort® operates across a diverse range of medical fields, including:
MicroPort®'s subsidiaries include MicroPort® Scientific (Shanghai), Shanghai MicroPort® Medical (Group), MicroPort® CardioFlow (02160.HK), MicroPort® NeuroScientific (02172.HK), MicroPort® Endovastec (688016.SH), MicroPort® Surgical, MicroPort® EP (688351.SH), MicroPort® CRM, MicroPort® Soaring CRM (Shanghai), MicroPort® MedBot (02252.HK), Suzhou MicroPort® Orthopedics (Group), MicroPort® Orthopedics, MicroPort® Urocare, MicroPort® MicroMatrix®, and MicroPort® GloMatrix, among others.
Global Innovation & Manufacturing
MicroPort® operates cutting-edge R&D and manufacturing hubs across China, the United States, France, Italy, Germany, the UK, and the Dominican Republic. Additionally, we have established industry-wide platforms including:
Together, these initiatives form an integrated industrial ecosystem that seamlessly connects innovation, supply chain efficiency, and market access. Through MicroMatrix® and GloMatrix, we enable the global adoption of hundreds of medical solutions, empowering healthcare institutions to deliver advanced patient care worldwide.
Thanks to this ecosystem, every five seconds or less, a patient somewhere in the world benefits from a MicroPort® life-changing solution.
A Trusted Partner in Healthcare
At MicroPort®, we stand alongside trusted partners, healthcare institutions, and patients, delivering cutting-edge solutions that fight diseases, enhance longevity, and improve quality of life. By partnering with leading minds and organizations, we bring the most advanced medical technologies to every community, every family, and every patient—wherever they are in the world.